O 
Otsuka Holdings Co 4578.T · JPY
Health Care · Pharmaceuticals · Tokyo Stock Exchange · 🇯🇵 Japan
11,965
+3.28%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥2.47trn
FY2016FY2025
Net income
¥363.15bn
FY2016FY2025
Free cash flow
¥315.74bn
FY2016FY2025
Shareholders' equity
¥3.03trn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥2.47trn | ¥2.33trn | ¥2.02trn | ¥1.74trn | ¥1.50trn | ¥1.42trn | ¥1.40trn | ¥1.29trn | ¥1.24trn | ¥1.20trn |
| Gross profit | ¥1.77trn | ¥1.67trn | ¥1.41trn | ¥1.17trn | ¥1.00trn | ¥983.08bn | ¥944.94bn | ¥850.16bn | ¥817.48bn | ¥789.22bn |
| Research and development | ¥352.84bn | ¥314.23bn | ¥307.80bn | ¥275.23bn | ¥232.30bn | ¥216.84bn | ¥215.79bn | ¥216.14bn | ¥175.56bn | ¥168.82bn |
| Operating income | ¥423.77bn | ¥396.85bn | ¥139.61bn | ¥150.32bn | ¥148.62bn | ¥198.58bn | ¥176.59bn | ¥69.64bn | ¥83.24bn | ¥84.55bn |
| Net income | ¥363.15bn | ¥343.12bn | ¥121.62bn | ¥133.91bn | ¥125.46bn | ¥148.14bn | ¥127.15bn | ¥82.49bn | ¥112.49bn | ¥92.56bn |
| Diluted earnings per share | 688.94 | 637.53 | 224.10 | 246.75 | 231.31 | 273.15 | 234.48 | 152.24 | 207.61 | 170.83 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥4.20trn | ¥3.74trn | ¥3.36trn | ¥3.10trn | ¥2.82trn | ¥2.63trn | ¥2.58trn | ¥2.48trn | ¥2.48trn | ¥2.48trn |
| Cash and short-term investments | ¥534.64bn | ¥426.17bn | ¥513.34bn | ¥471.63bn | ¥410.68bn | ¥356.85bn | ¥334.04bn | ¥351.64bn | ¥453.00bn | ¥579.16bn |
| Total liabilities | ¥1.10trn | ¥961.08bn | ¥924.92bn | ¥840.26bn | ¥775.72bn | ¥744.37bn | ¥785.86bn | ¥744.37bn | ¥658.31bn | ¥739.85bn |
| Debt | — | ¥189.38bn | ¥214.19bn | ¥194.16bn | ¥212.45bn | ¥226.08bn | ¥253.32bn | ¥213.94bn | ¥249.74bn | ¥280.27bn |
| Shareholders' equity | ¥3.03trn | ¥2.73trn | ¥2.39trn | ¥2.23trn | ¥2.01trn | ¥1.85trn | ¥1.77trn | ¥1.70trn | ¥1.79trn | ¥1.71trn |
| Shares outstanding | 527m | 538m | 543m | 543m | 542m | 542m | 542m | 542m | 542m | 542m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥403.58bn | ¥354.64bn | ¥283.23bn | ¥211.85bn | ¥228.86bn | ¥232.84bn | ¥192.63bn | ¥135.82bn | ¥102.83bn | ¥142.00bn |
| Capital spending | −¥87.84bn | −¥95.56bn | −¥90.74bn | −¥60.95bn | −¥52.45bn | −¥48.80bn | −¥48.60bn | −¥57.08bn | −¥54.15bn | −¥44.38bn |
| Free cash flow | ¥315.74bn | ¥259.08bn | ¥192.50bn | ¥150.90bn | ¥176.41bn | ¥184.04bn | ¥144.03bn | ¥78.75bn | ¥48.68bn | ¥97.62bn |
| Dividends paid | −¥70.97bn | −¥66.76bn | −¥55.65bn | −¥55.56bn | −¥55.98bn | −¥55.70bn | −¥55.56bn | −¥55.30bn | −¥54.86bn | −¥54.70bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥702.05bn | ¥630.34bn | ¥650.15bn | ¥637.98bn | ¥597.93bn | ¥582.84bn | ¥599.78bn | ¥621.15bn |
| Gross profit | ¥510.23bn | ¥456.25bn | ¥457.41bn | ¥457.02bn | ¥429.15bn | ¥426.19bn | ¥422.09bn | ¥454.62bn |
| Operating income | ¥145.71bn | ¥114.66bn | ¥74.92bn | ¥117.05bn | ¥96.04bn | ¥124.42bn | ¥135.81bn | ¥134.77bn |
| Net income | ¥117.26bn | ¥98.35bn | ¥65.49bn | ¥124.13bn | ¥88.53bn | ¥85.00bn | ¥151.45bn | ¥83.88bn |
| Diluted earnings per share | 222.75 | 186.82 | 124.25 | 235.49 | 167.96 | 161.25 | 281.40 | 155.85 |
| Cash from operations | ¥108.22bn | ¥108.88bn | ¥84.69bn | ¥106.16bn | ¥107.30bn | ¥105.43bn | ¥72.08bn | ¥149.52bn |
| Capital spending | −¥19.78bn | −¥25.16bn | −¥23.75bn | −¥18.42bn | −¥25.58bn | −¥20.09bn | −¥27.51bn | −¥20.35bn |
| Free cash flow | ¥88.44bn | ¥83.73bn | ¥60.94bn | ¥87.74bn | ¥81.72bn | ¥85.34bn | ¥44.57bn | ¥129.17bn |
| Total assets | ¥4.40trn | ¥4.21trn | ¥4.20trn | ¥3.96trn | ¥3.79trn | ¥3.69trn | ¥3.74trn | ¥3.60trn |
| Cash and short-term investments | ¥469.55bn | ¥538.30bn | ¥534.64bn | ¥492.14bn | ¥411.11bn | ¥407.50bn | ¥426.17bn | ¥515.11bn |
| Debt | ¥116.80bn | ¥29.67bn | ¥148.91bn | ¥57.86bn | ¥144.30bn | ¥126.26bn | ¥28.50bn | ¥191.19bn |
| Shareholders' equity | ¥3.24trn | ¥3.11trn | ¥3.03trn | ¥2.86trn | ¥2.72trn | ¥2.65trn | ¥2.73trn | ¥2.51trn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 12.4% | 11.7% | 5.5% |
| Operating income | 41.3% | 16.4% | 10.8% |
| Net income | 39.5% | 19.6% | 15.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 71.7% | 70.3% | 69.7% | 68.7% |
| Operating margin | 17.1% | 13.0% | 12.7% | 11.2% |
| Net margin | 14.7% | 11.2% | 10.8% | 9.6% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 12.9 | 13.5 | 23.6 | 17.4 | 18.0 | 16.2 | 20.8 | 29.5 | 23.8 | 29.8 |
| Price to sales | 1.9 | 2.0 | 1.4 | 1.3 | 1.5 | 1.7 | 1.9 | 1.9 | 2.2 | 2.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 15 years. Last went ex-dividend on 29 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 100.00 | 190.00 | 120.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.